These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15312830)

  • 1. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
    Farivar AS; Woolley SM; Naidu BV; Fraga CH; Byrne K; Thomas R; Salzman AL; Szabo CS; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):993-1002. PubMed ID: 15312830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FR167653 reduces obliterative airway disease in rats.
    Farivar AS; Mackinnon-Patterson B; Woolley S; Namkung J; Shimamoto A; Verrier ED; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):985-92. PubMed ID: 15312829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
    Farivar AS; Mackinnon-Patterson B; McCourtie AS; Namkung J; Ward PA; Mulligan MS
    Exp Mol Pathol; 2005 Jun; 78(3):190-7. PubMed ID: 15924870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of poly (ADP) ribose synthetase in lung ischemia-reperfusion injury.
    Woolley SM; Farivar AS; Naidu BV; Salzman A; Szabo C; Thomas R; Fraga C; Mulligan MS
    J Heart Lung Transplant; 2004 Nov; 23(11):1290-6. PubMed ID: 15539128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.
    Farivar AS; Woolley SM; Fraga CH; Thomas R; Salzman AL; Szabo C; Mulligan MS
    Ann Thorac Surg; 2004 Jun; 77(6):1938-43. PubMed ID: 15172241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival.
    Farivar AS; McCourtie AS; MacKinnon-Patterson BC; Woolley SM; Barnes AD; Chen M; Jagtap P; Szabó C; Salerno CT; Mulligan MS
    Ann Thorac Surg; 2005 Sep; 80(3):950-6. PubMed ID: 16122462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
    Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
    J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
    Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
    Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No gender difference in development of obliterative airway disease in rat tracheal allografts.
    Antus B; Fillinger J; Sebe A; Jeney C; Soltesz I; Horvath I
    Exp Mol Pathol; 2006 Dec; 81(3):235-8. PubMed ID: 16859678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas.
    Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J
    J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts.
    Fillinger J; Antus B
    Exp Lung Res; 2010 Dec; 36(10):625-31. PubMed ID: 20860540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat.
    Kallio EA; Koskinen PK; Aavik E; Vaali K; Lemstöm KB
    J Clin Invest; 1997 Dec; 100(12):2984-94. PubMed ID: 9399944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
    Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
    Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
    J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory epithelial expression of integrin alphaVbeta6 in chronic progressive allograft rejection.
    Dosanjh A; Ikonen T; Morris R
    J Heart Lung Transplant; 2004 Apr; 23(4):456-60. PubMed ID: 15063405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.
    Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB
    J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of airway obliteration by ciprofloxacin in experimental posttransplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Rentsch K; Vogt P; Russi EW; Boehler A
    Transplantation; 2008 Mar; 85(5):726-31. PubMed ID: 18337667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-allergic agent tranilast decreases development of obliterative airway disease in rat model of heterotopic tracheal transplantation.
    Okada Y; Matsumura Y; Shimada K; Sado T; Oyaizu T; Sugawara T; Matsuda Y; Hoshikawa Y; Takahashi H; Sato M; Kondo T
    J Heart Lung Transplant; 2004 Dec; 23(12):1392-5. PubMed ID: 15607669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.